Compounds > 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Disease, Pulmonary

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Disease, Pulmonary in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, TL1
Tang, MC1
Kuo, LM1
Chang, WD1
Chung, PJ1
Chang, YW1
Fang, YC1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Disease, Pulmonary

ArticleYear
YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
    Toxicology and applied pharmacology, 2012, Apr-15, Volume: 260, Issue:2

    Topics: Animals; Colforsin; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinase

2012